Literature DB >> 9690058

Genetic studies of polymorphisms in ten non-insulin-dependent diabetes mellitus candidate genes in Tamil Indians from Pondichery.

F Leprêtre1, N Vionnet, S Budhan, C Dina, K L Powell, E Génin, A K Das, V Nallam, P Passa, P Froguel.   

Abstract

We report a study of 10 candidate genes presumably involved in diabetes or insulin resistance or obesity among Pondicherian Tamil Indians, an isolated population with a high prevalence of diabetes. Forty-nine families with at least two affected patients in the sibship (567 individuals) were selected and tested by PCR-RFLP techniques for reported mutations in 10 diabetes or obesity candidate genes: glucagon receptor, insulin receptor substrate 1, insulin receptor, human beta 3 adrenergic receptor, fatty acid binding protein 2, mitochondrial tRNA(Leu(UUR)), sulphonylurea receptor, human uncoupling protein and the glycogen-associated regulatory subunit of protein phosphatase-1. Glucokinase gene was also screened for mutations. No mutations were found in glucokinase, glucagon receptor and mitochondrial genes in any of the 49 probands. Frequencies of polymorphisms at other loci were similar to those reported in Caucasian populations, except for 4 of the loci at which a higher frequency of variants was observed: human beta 3 adrenergic receptor, human uncoupling type 1 protein, fatty acid binding protein 2 and the glycogen-associated regulatory subunit of protein phosphatase-1. However, no evidence of association between any of these gene variants and non-insulin-dependent diabetes mellitus (NIDDM) or quantitative traits related to NIDDM (including body mass index, waist/hip ratio, insulinaemia, glycaemia, triglycerides and total cholesterol) was found in our sample. These results suggest that none of these gene variants commonly found in the Pondicherian Tamil population of South India is a major NIDDM predisposing locus, although it cannot be excluded that they may contribute to the polygenic background of the metabolic syndrome in Pondichery.

Entities:  

Mesh:

Year:  1998        PMID: 9690058

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  7 in total

Review 1.  Candidate genes for type 2 diabetes.

Authors:  Hemang Parikh; Leif Groop
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

2.  Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes: a meta-analysis of 27 studies.

Authors:  A Jellema; M P A Zeegers; E J M Feskens; P C Dagnelie; R P Mensink
Journal:  Diabetologia       Date:  2003-06-18       Impact factor: 10.122

3.  Associations between two single-nucleotide polymorphisms (rs1801278 and rs2943641) of insulin receptor substrate 1 gene and type 2 diabetes susceptibility: a meta-analysis.

Authors:  Qiuyan Li; Yuandong Qiao; Chuntao Wang; Guangfa Zhang; Xuelong Zhang; Lidan Xu
Journal:  Endocrine       Date:  2015-11-18       Impact factor: 3.633

4.  The A54T polymorphism at the intestinal fatty acid binding protein 2 is associated with insulin resistance in glucose tolerant Caucasians.

Authors:  K C Chiu; L M Chuang; C Yoon
Journal:  BMC Genet       Date:  2001-03-28       Impact factor: 2.797

5.  Ethnicity Differences in the Association of UCP1-3826A/G, UCP2-866G/A and Ala55Val, and UCP3-55C/T Polymorphisms with Type 2 Diabetes Mellitus Susceptibility: An Updated Meta-Analysis.

Authors:  Rong Huang; Tingting Cai; Yunting Zhou; Yuming Wang; Huiying Wang; Ziyang Shen; Wenqing Xia; Xiaomei Liu; Bo Ding; Yong Luo; Rengna Yan; Huiqin Li; Jindan Wu; Jianhua Ma
Journal:  Biomed Res Int       Date:  2021-10-19       Impact factor: 3.411

Review 6.  Role of Glucagon and Its Receptor in the Pathogenesis of Diabetes.

Authors:  Yunbo Jia; Yang Liu; Linlin Feng; Siyu Sun; Guangwei Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

Review 7.  Type 2 diabetes in South Asians: a pathophysiologic focus on the Asian-Indian epidemic.

Authors:  Mandeep Bajaj; Mary Ann Banerji
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 5.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.